- Home
- OTLK vs VTSI Comparison
OTLK vs VTSI Comparison
Compare OTLK & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- VTSI
- Stock Information
- Founded
- OTLK 2010
- VTSI 1993
- Country
- OTLK United States
- VTSI United States
- Employees
- OTLK N/A
- VTSI N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- VTSI Miscellaneous manufacturing industries
- Sector
- OTLK Health Care
- VTSI Consumer Discretionary
- Exchange
- OTLK Nasdaq
- VTSI Nasdaq
- Market Cap
- OTLK 64.6M
- VTSI 75.9M
- IPO Year
- OTLK 2016
- VTSI N/A
- Fundamental
- Price
- OTLK $1.83
- VTSI $6.22
- Analyst Decision
- OTLK Strong Buy
- VTSI Strong Buy
- Analyst Count
- OTLK 5
- VTSI 2
- Target Price
- OTLK $21.00
- VTSI $14.50
- AVG Volume (30 Days)
- OTLK 892.5K
- VTSI 49.4K
- Earning Date
- OTLK 02-12-2025
- VTSI 11-12-2024
- Dividend Yield
- OTLK N/A
- VTSI N/A
- EPS Growth
- OTLK N/A
- VTSI N/A
- EPS
- OTLK N/A
- VTSI 0.53
- Revenue
- OTLK N/A
- VTSI $31,771,647.00
- Revenue This Year
- OTLK N/A
- VTSI N/A
- Revenue Next Year
- OTLK $396.84
- VTSI $24.06
- P/E Ratio
- OTLK N/A
- VTSI $11.81
- Revenue Growth
- OTLK N/A
- VTSI N/A
- 52 Week Low
- OTLK $0.87
- VTSI $5.63
- 52 Week High
- OTLK $12.85
- VTSI $17.68
- Technical
- Relative Strength Index (RSI)
- OTLK 39.18
- VTSI 35.97
- Support Level
- OTLK $1.79
- VTSI $6.10
- Resistance Level
- OTLK $2.26
- VTSI $6.70
- Average True Range (ATR)
- OTLK 0.18
- VTSI 0.22
- MACD
- OTLK 0.00
- VTSI -0.04
- Stochastic Oscillator
- OTLK 6.09
- VTSI 13.19
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.